Related Experiment Video
Updated: Aug 30, 2026

Detecting Glycogen in Peripheral Blood Mononuclear Cells with Periodic Acid Schiff Staining
Published on: December 23, 2014
Liver glycogenosis as early manifestation in type 1 diabetes mellitus
L Carcione1, F Lombardo, M F Messina
1Department of Pediatrics, University of Messina, Messina, Italy.
Insights
Hepatic glycogenosis, a liver condition, can manifest during Type 1 diabetes mellitus (T1DM) onset or early treatment. This occurs due to high blood sugar and insulin therapy, resolving with improved diabetes control.
Area of Science:
- Pediatrics
- Endocrinology
- Hepatology
Background:
- Type 1 diabetes mellitus (T1DM) presentation in children typically involves metabolic derangements, not liver dysfunction.
- Hepatic glycogenosis is characterized by excessive glycogen accumulation in liver cells.
Observation:
- Two pediatric cases presented with clinical and biochemical signs of hepatic glycogenosis at T1DM onset.
- Liver abnormalities (hepatomegaly, elevated aminotransferases) appeared days after initiating insulin therapy, not at T1DM diagnosis.
- Initial liver function and dimensions were normal despite severe hyperglycemia at T1DM onset.
Findings:
- Hepatic glycogenosis developed during T1DM treatment, linked to supraphysiological insulin doses and hyperglycemia.
- Patients experienced complete physical and biochemical recovery within weeks of improved glycemic control.
- This suggests hepatic glycogenosis can be an early, albeit uncommon, manifestation of T1DM.
Implications:
- Clinicians should consider hepatic glycogenosis in children with T1DM, particularly during initial intensive insulin therapy.
- Recognizing this association aids in accurate diagnosis and management of T1DM complications.
- Further research is needed to understand the prevalence and mechanisms of T1DM-associated hepatic glycogenosis.
Abstract:
Clinical symptoms and biochemical findings related to liver dysfunction are not generally reported among the presentation features of Type 1 diabetes mellitus (T1DM) in infancy and childhood. To our knowledge this is the first paper reporting two children with a clinical and biochemical picture of hepatic glycogenosis at the presentation of T1DM. In both cases at beginning of insulin therapy liver function and dimensions were absolutely normal, even though glycometabolic status had been severely altered for many days at T1DM onset. Both hepatomegaly and aminotransferase abnormalities were first found only some days after the institution of treatment with supraphysiological insulin doses. In both patients the improvement of glycometabolic control under insulin therapy was followed within some weeks by a complete physical and biochemical recovery, as typically reported in hepatic glycogenosis. These case reports demonstrate that hepatic glycogenosis can occur at any stage of T1DM and may even be one of its earliest manifestations, together with those classically reported at the onset of T1DM. Since long-standing hyperglycaemia and overinsulinisation are metabolic pre-requisites for hepatic glycogen storage, liver glycogenosis should be expected to be not uncommon during the first phases of T1DM, especially in the cases who are initially treated with supraphysiological insulin doses.
Related Concept Videos
Type I Diabetes III: Clinical Manifestations
Type I Diabetes I: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Diabetes: Symptoms, Diagnosis, and Complications
